{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:56:13Z","timestamp":1792457773717,"version":"4.5.0"},"reference-count":49,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T00:00:00Z","timestamp":1424304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In patients with von <jats:styled-content style=\"fixed-case\">W<\/jats:styled-content>illebrand disease (<jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content>), the absence of von <jats:styled-content style=\"fixed-case\">W<\/jats:styled-content>illebrand factor (<jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content>) antigen leads to the premature loss of endogenous circulating secreted factor <jats:styled-content style=\"fixed-case\">VIII<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">FVIII<\/jats:styled-content>), thereby resulting in the dual defect in haemostasis. Consequently, correcting the <jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content> deficiency also acts to correct the associated defect in <jats:styled-content style=\"fixed-case\">FVIII<\/jats:styled-content> activity because exogenous <jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content> forms complexes with and protects endogenous <jats:styled-content style=\"fixed-case\">FVIII<\/jats:styled-content>. The purpose of this study was to summarise relevant aspects of the interaction between <jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">FVIII<\/jats:styled-content> and to analyse their effects on <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content> treatment. Differences in the <jats:styled-content style=\"fixed-case\">VWF<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">FVIII<\/jats:styled-content> ratios in coagulation factor concentrates should be considered when treating <jats:styled-content style=\"fixed-case\">VWD<\/jats:styled-content>.<\/jats:p>","DOI":"10.1111\/ejh.12514","type":"journal-article","created":{"date-parts":[[2015,1,21]],"date-time":"2015-01-21T11:48:23Z","timestamp":1421840903000},"page":"449-454","source":"Crossref","is-referenced-by-count":11,"title":["Interaction between VWF and FVIII in treating VWD"],"prefix":"10.1111","volume":"95","author":[{"given":"Wolfgang","family":"Miesbach","sequence":"first","affiliation":[{"name":"Medical Clinic III Institute of Transfusion Medicine Goethe University Frankfurt Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Berntorp","sequence":"additional","affiliation":[{"name":"Centre for Thrombosis and Haemostasis Skane University Hospital Lund University Malm\u00f6 Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,2,19]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.11.3150.bloodjournal85113150"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02572.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1055\/s-0037-1619106","article-title":"Clinical assessment of efficacy and safety of DDAVP","volume":"1","author":"Miesbach W","year":"2010","journal-title":"Hamostaseologie"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01668.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01836069"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01435.x"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040403"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02146.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000214846"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000339426"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2003.10.004"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-540534"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01329.x"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)35234-1"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02005.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1990.tb15481.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)52225-0"},{"key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"17815","DOI":"10.1016\/S0021-9258(18)55200-5","article-title":"The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin\u2010activated human platelets","volume":"266","author":"Nesheim M","year":"1991","journal-title":"J Biol Chem"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)37260-5"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108788"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb03888.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20658"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-949668"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00893.x"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02663.x"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-02-0057"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01435.x"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1860.x"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-01-479527"},{"issue":"1","key":"e_1_2_8_31_1","first-page":"S32","article-title":"Development of a plasma\u2010 and albumin\u2010free recombinant von Willebrand factor","volume":"29","author":"Turecek PL","year":"2009","journal-title":"Hamostaseologie"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02809.x"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006745"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613747"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.21.5.731"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90166-3"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2011.01611.x"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12498"},{"key":"e_1_2_8_39_1","first-page":"117","article-title":"Evidence\u2010based recommendations on the treatment of von Willebrand disease in Italy","volume":"7","author":"Mannucci PM","year":"2009","journal-title":"Blood Transfus"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2007.01643.x"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000167658.85143.49"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.077263"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613225"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02588.x"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01299.x"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-10-0631"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01901.x"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02758.x"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01273.x"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1002\/elps.200900270"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fejh.12514","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.12514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T17:14:41Z","timestamp":1696353281000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.12514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,19]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1111\/ejh.12514"],"URL":"https:\/\/doi.org\/10.1111\/ejh.12514","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,19]]}}}